Skip to main content


Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats

Fig. 2

Occurrence of atrial and ventricular premature beats in hypertensive rats. Representative electrocardiographic tracings for normotensive rats (WKY, trace a), hypertensive rats (SHR, traces b, c) and empagliflozin-treated hypertensive rats (EMPA, traces d, e). Premature beats were specifically labeled as APC for an atrial origin, and VPC for a ventricular origin. The number of APC and VPC for each rat (f, g) was calculated from 5 min ECG recording

Back to article page